Zurueck zur Suche

Reporte zur Charge UJ593AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

3Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
UT 1 AK 1 CO 1

VAERS 2544171

MSP VACCINE COMPANY · DTAP+IPV+HIB+HEPB (VAXELIS) · Charge UJ593AA

mild
Staat
UT
Alter
-
Geschlecht
M
Eingang
28.12.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site bruising Injection site erythema Injection site pain Injection site rash Injection site swelling Injection site warmth

Symptomtext

A rash on the right hip that was bruising, red and warm to touch; Had the normal adverse reaction of injection site pain and swelling; Had the normal adverse reaction of injection site pain and swelling; This non-serious spontaneous safety report, with reference number 02264111/ 02264110 was received by a partner on 07-OCT-2022 and forwarded on 10-OCT-2022 from a physician. The reporter did not assess the causal relationship between Vaxelis and the reported events of "A rash on the right hip that was bruising, red and warm to touch" and "Had the normal adverse reaction of injection site pain and swelling". Further information is expected. Significant follow-up information was received on 28-OCT-2022 from a HCP. The reporter assessed the causal relationship between Vaxelis and the reported events of "A rash on the right hip that was bruising, red and warm to touch" and "Had the normal adverse reaction of injection site pain and swelling". No further information is expected.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2198939

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ593AA

mild
Staat
AK
Alter
0,5
Geschlecht
F
Eingang
25.03.2022
Impfdatum
23.03.2022
Beginn
23.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Diarrhoea Vomiting

Symptomtext

2 hours after receiving vaccines, started vomiting, then a break, the started again 6 hours after vaccines lasting until 10 hours after. Vomited 25 times and had 2 bouts of diarrhea. Was then taken by parents to Medical Center ED, and seen at the pediatricians office for a follow up today 03/25/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277676

SANOFI PASTEUR · DTAP + IPV + HIB (PENTACEL) · Charge UJ593AA

gering
Staat
CO
Alter
-
Geschlecht
M
Eingang
14.05.2022
Impfdatum
05.05.2022
Beginn
05.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product preparation issue

Symptomtext

received the DTap-IPV portion of PENTACEL in the office on 05MAY2022 without reconstituting with the Hib portion with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received a other health professional. This case involves a 4 months old male patient who received the dtap-ipv portion of pentacel in the office on 05-May-2022 without reconstituting with the hib portion with no reported adverse event while receiving vaccine DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE [PENTACEL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13); and ROTAVIRUS VACCINE LIVE REASSORT ORAL 5V (ROTATEQ). On 05-May-2022, the patient received 0.5 ml dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE (lot : UJ593AA and expiry date: 18-Dec-2022 for powder vial; lot: U7054AA and expiry date: 18-Dec-2022 for liquid vial) via intramuscular route for immunization. It was reported that the patient received the dtap-ipv portion of pentacel in the office on 05-May-2022 without reconstituting with the hib portion with no reported adverse event (product preparation issue) following the administration of DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event (received the DTap-IPV portion of PENTACEL in the office on 05MAY2022 without reconstituting with the Hib portion with no reported adverse event). Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-